{
    "clinical_study": {
        "@rank": "88952", 
        "arm_group": [
            {
                "arm_group_label": "Vitamin D + fish oil placebo", 
                "arm_group_type": "Active Comparator", 
                "description": "Vitamin D3 (cholecalciferol), 2000 IU per day\nFish oil placebo"
            }, 
            {
                "arm_group_label": "Vitamin D placebo + fish oil", 
                "arm_group_type": "Active Comparator", 
                "description": "Vitamin D placebo\nOmacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg. of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA])"
            }, 
            {
                "arm_group_label": "Vitamin D placebo + fish oil placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "Vitamin D placebo\nfish oil placebo"
            }, 
            {
                "arm_group_label": "Vitamin D + fish oil", 
                "arm_group_type": "Active Comparator", 
                "description": "Vitamin D (cholecalciferol), 2000 IU per day\nOmacor, 1 capsule per day. Each capsule of Omacor contains 840 milligrams of marine omega-3 fatty acids (465 mg. of eicosapentaenoic acid [EPA] and 375 mg of docosahexaenoic acid [DHA])"
            }
        ], 
        "brief_summary": {
            "textblock": "The VITamin D and OmegA-3 Trial (VITAL; NCT 01169259) is a randomized clinical trial in\n      25,875 U.S. men and women investigating whether taking daily dietary supplements of vitamin\n      D3 (2000 IU) or omega-3 fatty acids (Omacor fish oil, 1 gram) reduces the risk of developing\n      cancer, heart disease, and stroke in people who do not have a prior history of these\n      illnesses. This ancillary study is being conducted among participants in VITAL and will\n      examine whether vitamin D or omega-3 fatty acids, compared to placebo, reduce the incidence\n      and/or progression of age-related macular degeneration (AMD)."
        }, 
        "brief_title": "Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)", 
        "completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "condition": "Age-related Macular Degeneration", 
        "condition_browse": {
            "mesh_term": "Macular Degeneration"
        }, 
        "detailed_description": {
            "textblock": "This ancillary study to the VITamin D and OmegA-3 TriaL (VITAL) will examine whether vitamin\n      D3 and omega-3 fatty acids can help prevent the onset or progression of age-related macular\n      degeneration (AMD). The study will also examine whether vitamin D3 and omega-3 fatty acids\n      interact with each other, or with specific genes associated with AMD or vitamin D3 or\n      omega-3 fatty acid metabolic activity, to affect the risk of developing AMD."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All participants in VITAL (NCT 01169259) are eligible to participate in this\n             ancillary study.\n\n        Exclusion Criteria:\n\n          -  None"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "N/A", 
            "minimum_age": "50 Years"
        }, 
        "enrollment": {
            "#text": "25875", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "January 31, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01782352", 
            "org_study_id": "2012P001797", 
            "secondary_id": [
                "R01EY021900", 
                "2012P000724"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": [
                    "Vitamin D placebo + fish oil", 
                    "Vitamin D + fish oil"
                ], 
                "intervention_name": "Omega-3 fatty acids (fish oil)", 
                "intervention_type": "Drug", 
                "other_name": "Omacor"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D + fish oil placebo", 
                    "Vitamin D + fish oil"
                ], 
                "intervention_name": "Vitamin D3", 
                "intervention_type": "Dietary Supplement", 
                "other_name": "cholecalciferol"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D placebo + fish oil", 
                    "Vitamin D placebo + fish oil placebo"
                ], 
                "intervention_name": "Vitamin D3 placebo", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": [
                    "Vitamin D + fish oil placebo", 
                    "Vitamin D placebo + fish oil placebo"
                ], 
                "intervention_name": "Fish oil placebo", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Cholecalciferol", 
                "Vitamin D", 
                "Ergocalciferols", 
                "Vitamins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "age-related macular degeneration", 
            "incidence", 
            "progression"
        ], 
        "lastchanged_date": "May 29, 2014", 
        "link": {
            "description": "VITAL study website", 
            "url": "http://vitalstudy.org"
        }, 
        "location": {
            "facility": {
                "address": {
                    "city": "Boston", 
                    "country": "United States", 
                    "state": "Massachusetts", 
                    "zip": "02215"
                }, 
                "name": "Brigham and Women's Hospital"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "4", 
        "official_title": "Age-related Macular Degeneration (AMD) in the Vitamin D and Omega-3 Trial (VITAL)", 
        "overall_official": [
            {
                "affiliation": "Brigham and Women's Hospital", 
                "last_name": "Debra A Schaumberg, ScD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Brigham and Women's Hospital", 
                "last_name": "William G Christen, ScD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2017", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Report of a diagnosis of age-related macular degeneration confirmed by medical record review.", 
            "measure": "Age-related macular degeneration", 
            "safety_issue": "No", 
            "time_frame": "5 years"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01782352"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Brigham and Women's Hospital", 
            "investigator_full_name": "William G. Christen", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Brigham and Women's Hospital", 
        "sponsors": {
            "collaborator": {
                "agency": "National Eye Institute (NEI)", 
                "agency_class": "NIH"
            }, 
            "lead_sponsor": {
                "agency": "Brigham and Women's Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "July 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Factorial Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor), Primary Purpose: Prevention", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}